List of voters for the quote

We anticipate this study will confirm the benefit and safety profile we observed in the TRAILBLAZER-ALZ Phase 2 study and believe that patients and physicians will be well served by having the full Phase 3 data available alongside our Phase 2 data when they need to make treatment decisions, we are committed to working with the FDA to ensure the fastest possible path to bring this potential medicine to patients in need.

This page is about the voters of this citizen quote.